Sign in
RASP Stock Price, Chart, Stats & News
Actavia Life Sciences, Inc.
Save
Actavia Life Sciences, Inc. (RASP) does not currently pay a dividend.
385,906
Market cap
–
Current P/E
–
Forward P/E
RASP chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.
Similar securities
Based on sector and market capitalization
Report issue